Discordant serum CA 125 values in commercial immunoassays
- 1 April 1993
- journal article
- research article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 49 (1-2) , 99-103
- https://doi.org/10.1016/0028-2243(93)90132-v
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- CA 125 half-life in ovarian cancer: a multivariate survival analysisBritish Journal of Cancer, 1993
- Comparison of five immunoassay procedures for the ovarian carcinoma-associated antigenic determinant CA 125 in serumEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1992
- Distribution of CA 125 in embryonic tissues and adult derivatives of the fetal peridermAmerican Journal of Obstetrics and Gynecology, 1990
- The CA 125 tumour-associated antigen: a review of the literatureHuman Reproduction, 1989
- Correlation of an enzyme immunoassay with the radioimmunoassay for CA-125American Journal of Obstetrics and Gynecology, 1988
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981